Factors influencing insulin sensitivity in patients with mild primary hyperparathyroidism before and after parathyroidectomy

Scandinavian Journal of Clinical and Laboratory Investigation

Volumn 72, Issue 2, 2012, Pages 92-99

  Almqvist, Erik G ^a   Bondeson, Anne Greth ^b   Bondeson, Lennart ^b   Mellström, Dan ^c   Svensson, Johan ^a  

^a CENTRAL HOSPITAL   (Sweden)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

^c UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Adiponectin; Erythropoietin; Hyperparathyroidism; Insulin; Osteocalcin; PTH; SHBG

Indexed keywords

ADIPONECTIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ERYTHROPOIETIN; ESTROGEN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; OSTEOCALCIN; SEX HORMONE BINDING GLOBULIN; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GLUCOSE METABOLISM; HUMAN; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID METABOLISM; MALE; PARATHYROIDECTOMY; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIMARY HYPERPARATHYROIDISM; PRIORITY JOURNAL;

ADIPONECTIN; AGED; AGED, 80 AND OVER; BLOOD GLUCOSE; ERYTHROPOIETIN; FEMALE; HUMANS; HYPERPARATHYROIDISM, PRIMARY; INSULIN; INSULIN RESISTANCE; LIPIDS; MALE; MIDDLE AGED; OSTEOCALCIN; PARATHYROIDECTOMY;

EID: 84858403182     PISSN: 00365513     EISSN: 15027686     Source Type: Journal    
DOI: 10.3109/00365513.2011.634432     Document Type: Article

References (35)

1. Hedbäck G, Tisell LE, Bengtsson BA, Hedman I, Oden A. Premature death in patients operated on for primary hyper-parathyroidism. World J Surg 1990;14:829-35.
2. Andersson P, Rydberg E, Willenheimer R. Primary hyper-parathyroidism and heart disease-a review. Eur Heart J 2004; 25:1776-87. (Pubitemid 39330228)
3. Bilezikian JP, Khan AA, Potts JT Jr. Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the third international workshop. J Clin Endocrinol Metab 2009;94:335-9.
4. Taylor WH. The prevalence of diabetes mellitus in patients with primary hyperparathyroidism and among their relatives. Diabet Med 1991;8:683-7.
5. Lundgren E, Ljunghall S, Akerström G, Hetta J, Mallmin H, Rastad J. Case-control study on symptoms and signs of'asymptomatic'primary hyperparathyroidism. Surgery 1998;124:980-5.
6. Nainby-Luxmoore JC, Langford HG, Nelson NC, Watson RL, Barnes TY. A case-comparison study of hypertension and hyper-parathyroidism. J Clin Endocrinol Metab 1982;55:303-6.
7. Piovesan A, Molineri N, Casasso F, Emmolo I, Ugliengo G, Cesario F, Borretta G. Left ventricular hypertrophy in primary hyperparathyroidism. Effects of successful parathyroi-dectomy. Clin Endocrinol (Oxf) 1999;50:321-8. (Pubitemid 29166711)
8. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 1990;322:1561-6. (Pubitemid 20176696)
9. Trayhurn P, Beattie JH. Physiological role of adipose tissue: white adipose tissue as an endocrine and secretory organ. Proc Nutr Soc 2001;60:329-39. (Pubitemid 32772448)
10. Gustafson B. Adipose tissue, inflammation and atherosclerosis. J Atheroscler Thromb 2010;17:332-41.
11. Behre CJ, Brohall G, Hulthe J, Fagerberg B. Serum adi-ponectin in a population sample of 64-year-old women in relation to glucose tolerance, family history of diabetes, autoimmunity, insulin sensitivity, C-peptide, and inflamma-tion. Metabolism 2006;55:188-94. (Pubitemid 43098986)
12. Laaksonen DE, Niskanen L, Punnonen K, Nyyssönen K, Tuomainen TP, Salonen R, Rauramaa R, Salonen JT. Sex hormones, inflammation and the metabolic syndrome: a population-based study. Eur J Endocrinol 2003; 149:601-8. (Pubitemid 38054707)
13. Lindstedt G, Lundberg PA, Lapidus L, Lundgren H, Bengts-son C, Björntorp P. Low sex-hormone-binding globulin concentration as independent risk factor for development of NIDDM. 12-yr follow-up of population study of women in Gothenburg, Sweden. Diabetes 1991;40:123-8.
14. Ding EL, Song Y, Manson JE, Hunter DJ, Lee CC, Rifai N, Buring JE, Gaziano JM, Liu S. Sex hormone-binding globulin and risk of type 2 diabetes in women and men. N Engl J Med 2009;361:1152-63.
15. Yeap BB, Chubb SA, Flicker L, McCaul KA, Ebeling PR, Beilby JP, Norman PE. Reduced serum total osteocalcin is associated with metabolic syndrome in older men via waist circumference, hyperglycemia, and triglyceride levels. Eur J Endocrinol 2010;163:265-72.
16. Fried W. Erythropoietin and erythropoiesis. Exp Hematol 2009;37:1007-15.
17. Santhanam AV, d'Uscio LV, Katusic ZS. Cardiovascular effects of erythropoietin an update. Adv Pharmacol 2010;60:257-85.
18. Trunzo JA, McHenry CR, Schulak JA, Wilhelm SM. Effect of parathyroidectomy on anemia and erythropoietin dosing in end-stage renal disease patients with hyperparathyroid-ism. Surgery 2008;144:915-8.
19. Boxer M, Ellman L, Geller R, Wang CA. Anemia in primary hyperparathyroidism. Arch Intern Med 1977;137:588-93.
20. Almqvist EG, Bondeson AG, Bondeson L, Nissborg A, Smedgård P, Svensson SE. Cardiac dysfunction in mild primary hyperparathyroidism assessed by radionuclide angiography and echocardiography before and after parathy-roidectomy. Surgery 2002;132:1126-32. (Pubitemid 36026965)
21. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;18:499-502.
22. Du Bois D, Du Bois EF. A formula to estimate the approximate surface area if height and weight be known. Arch Int Med 1916;17:863-71.
23. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-9. (Pubitemid 15018832)
24. Ascaso JF, Pardo S, Real JT, Lorente RI, Priego A, Carmena R. Diagnosing insulin resistance by simple quantitative methods in subjects with normal glucose metabolism. Diabetes Care 2003;26:3320-5. (Pubitemid 37466894)
25. Graham I, Atar D, Borch-Johnsen K, Boysen G, Burell G, Cifkova R, Dallongeville J, De Backer G, Ebrahim S, Gjelsvik B, Herrmann-Lingen C, Hoes A, Humphries S, Knapton M, Perk J, Priori SG, Pyorala K, Reiner Z, Ruilope L, Sans-Menendez S, Scholte op Reimer W, Weissberg P, Wood D, Yarnell J, Zamorano JL, Walma E, Fitzgerald T, Cooney MT, Dudina A. European guidelines on cardiovascular disease prevention in clinical practice: executive summary: Fourth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice. Eur Heart J 2007;28:2375-414. (Pubitemid 47542237)
26. Reaven GM. Pathophysiology of insulin resistance in human disease. Physiol Rev 1995;75:473-86.
27. Delfini E, Petramala L, Caliumi C, Cotesta D, De Toma G, Cavallaro G, Panzironi G, Diacinti D, Minisola S, D'Erasmo E, Mazzuoli GF, Letizia C. Circulating leptin and adiponectin levels in patients with primary hyperparathy-roidism. Metabolism 2007;56:30-6. (Pubitemid 44856740)
28. Spranger J, Kroke A, Möhlig M, Bergmann MM, Ristow M, Boeing H, Pfeiffer AF. Adiponectin and protection against type 2 diabetes mellitus. Lancet 2003;361:226-8. (Pubitemid 36126226)
29. Almqvist EG, Becker C, Bondeson AG, Bondeson L, Svens-son J. Increase of bioavailable testosterone is associated with gain in bone mineral density after cure of primary hyper-parathyroidism in postmenopausal women. Clin Endocrinol (Oxf) 2006;64:58-62.
30. Fukumoto S, Martin TJ. Bone as an endocrine organ. Trends Endocrinol Metab 2009;20:230-6.
31. Motyl KJ, McCabe LR, Schwartz AV. Bone and glucose metabolism: a two-way street. Arch Biochem Biophys 2010;503:2-10.
32. Bollerslev J, Rosen T, Mollerup CL, Nordenström J, Bara-nowski M, Franco C, Pernow Y, Isaksen GA, Godang K, Ueland T, Jansson S. Effect of surgery on cardiovascular risk factors in mild primary hyperparathyroidism. J Clin Endocrinol Metab 2009;94:2255-61.
33. Bhadada SK, Bhansali A, Ahluwalia J, Chanukya GV, Behera A, Dutta P. Anaemia and marrow fibrosis in patients with primary hyperparathyroidism before and after curative parathyroidectomy. Clin Endocrinol (Oxf) 2009;70: 527-32.
34. Kotzmann H, Abela C, Heindl J, Clodi M, Riedl M, Barnas U, Heinzl H, Niederle B, Geissler K, Waldhäusl W, Luger A. Effect of successful parathyroidectomy on hematopoi-etic progenitor cells and parameters of red blood cells in patients with primary hyperparathyroidism. Horm Metab Res 1997;29:387-92. (Pubitemid 27362063)
35. Sikole A. Pathogenesis of anaemia in hyperparathyroidism. Med Hypotheses 2000;54:236-8. (Pubitemid 30170968)